The collaborative epitranscriptome: bidirectional crosstalk between m(6)A methylation and noncoding RNAs in cancer pathogenesis and precision therapy.

Li N, Lu J, Zhang W

Open source

DOI
10.1016/j.intimp.2026.117352
Published
2026 Sep 11
Container
International immunopharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.intimp.2026.117352,
  title = {The collaborative epitranscriptome: bidirectional crosstalk between m(6)A methylation and noncoding RNAs in cancer pathogenesis and precision therapy.},
  author = {Li N and Lu J and Zhang W},
  year = {2026},
  journal = {International immunopharmacology},
  doi = {10.1016/j.intimp.2026.117352},
  url = {https://doi.org/10.1016/j.intimp.2026.117352}
}

RIS

TY  - JOUR
TI  - The collaborative epitranscriptome: bidirectional crosstalk between m(6)A methylation and noncoding RNAs in cancer pathogenesis and precision therapy.
AU  - Li N
AU  - Lu J
AU  - Zhang W
PY  - 2026
JO  - International immunopharmacology
DO  - 10.1016/j.intimp.2026.117352
UR  - https://doi.org/10.1016/j.intimp.2026.117352
ER  - 

APA

N, L., J, L., & W, Z. (2026). The collaborative epitranscriptome: bidirectional crosstalk between m(6)A methylation and noncoding RNAs in cancer pathogenesis and precision therapy.. International immunopharmacology. https://doi.org/10.1016/j.intimp.2026.117352

Source records